(Q37558726)

21 August 2017

0 references

1 reference

title

Iloperidone for schizophrenia: a review of the efficacy and safety profile for this newly commercialised second-generation antipsychotic (English)

1 reference

21 August 2017

0 references

1 reference

L Citrome

1

0 references

publication date

1 August 2009

1 reference

International Journal of Clinical Practice

21 August 2017

12

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

21 August 2017

63

1 reference

21 August 2017

8

1 reference

21 August 2017

1237-1248

1 reference

Efficacy of iloperidone in the treatment of schizophrenia: initial phase 3 studies

21 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2009.02142.X

Safety profile of iloperidone: a pooled analysis of 6-week acute-phase pivotal trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2009.02142.X

Long-term efficacy and safety of iloperidone: results from 3 clinical trials for the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2009.02142.X

Show me the evidence: using number needed to treat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2009.02142.X

Safety, tolerability, and effect of food on the pharmacokinetics of iloperidone (HP 873), a potential atypical antipsychotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2009.02142.X

10.1111/J.1742-1241.2009.02142.X

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference

PubMed ID

19624791